Amanda McEwen

Amanda McEwen has a diverse and extensive work experience in the field of clinical development and regulatory affairs. Amanda most recently served as the Vice President of Clinical Development at Salubris Biotherapeutics since January 2023. Prior to that, they held similar roles as the Vice President of Clinical Development at Elevian, Inc. from March 2022 to January 2023, and at Nocion Therapeutics, Inc. from February 2020 to March 2022. Amanda also worked as the Director of Clinical Development at Dicerna Pharmaceuticals, Inc. from July 2018 to February 2020, and as the Senior Clinical Scientist from November 2017 to June 2018. Amanda has also contributed their expertise as an Adjunct Faculty at Northeastern University since September 2019, teaching a Master's program in Regulatory Affairs for Drugs, Biologics, and Medical Devices. Amanda has held various other positions in their career, including Associate Director of Clinical Operations at Finch Therapeutics, Senior Clinical Project Manager at Intarcia Therapeutics, Inc. and Acorda Therapeutics, Inc., Clinical Trial Manager at Civitas Therapeutics, and Consultant at Pharmica Consulting LLC. Their career spans over a decade, showcasing their knowledge and proficiency in the field.

Amanda McEwen holds a Bachelor of Arts degree in Psychology from the College of the Holy Cross. Following their undergraduate studies, they pursued further education at the University of York where they obtained a Master of Research Methods degree in Psychology.